MARTIN MARIETTA MATERIALS INC Stock Compensation Disclosure
Note K: Stock-Based Compensation
On May 19, 2016, the Company’s shareholders approved the Martin Marietta Amended and Restated Stock-Based Award Plan. The Martin Marietta Materials, Inc. Stock-Based Award Plan, as amended from time to time, along with the Amended Omnibus Securities Award Plan, originally approved in 1994 (collectively, the Plans), are still effective for awards made prior to 2017. The Company has been authorized by the Board of Directors to repurchase shares of the Company’s common stock for issuance under the stock-based award plans (see Note M).
The Company grants restricted stock awards under the Plans to a group of executive officers, key personnel and nonemployee members of the Board of Directors. The vesting of certain restricted stock awards is based on certain performance criteria over a specified period of time. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of those criteria. In addition, certain awards are granted to individuals to encourage retention and motivate key employees. These awards generally vest if the employee is continuously employed over a specified period of time and require no payment from the employee. Awards granted to nonemployee members of the Board of Directors vest immediately.
The fair value of stock-based award grants is expensed over the vesting period. Awards to employees eligible for retirement prior to the award becoming fully vested are expensed over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. Awards granted to nonemployee members of the Board of Directors are expensed immediately.
Additionally, an incentive compensation stock plan has been adopted under the Plans whereby certain participants may elect to use up to 50% of their annual incentive compensation to acquire units representing shares of the Company’s common stock at a 20% discount to the market value on the date of the incentive compensation award. Participants receive unrestricted shares of common stock in an amount equal to their respective units generally at the end of a 34-month period of additional employment from the date of award or at retirement beginning at age 62. All rights of ownership of the common stock convey to the participants upon the issuance of their respective shares at the end of the ownership-vesting period.
In 2026, the Company intends to submit to shareholders for approval a further Amended and Restated Stock-Based Award Plan. If approved, this updated plan will replace the existing stock-based award plans with respect to future grants while maintaining the validity of all outstanding awards previously issued under the current Plans.
The following table summarizes information for restricted stock awards and incentive compensation stock awards for 2025:
|
|
Restricted Stock - |
|
|
Restricted Stock - |
|
|
Incentive Compensation Stock |
|
|||||||||||||||
|
|
Number of |
|
|
Weighted- |
|
|
Number of |
|
|
Weighted- |
|
|
Number of |
|
|
Weighted- |
|
||||||
January 1, 2025 |
|
|
191,534 |
|
|
$ |
370.27 |
|
|
|
88,504 |
|
|
$ |
468.71 |
|
|
|
15,543 |
|
|
$ |
497.76 |
|
Awarded |
|
|
55,701 |
|
|
$ |
510.86 |
|
|
|
32,254 |
|
|
$ |
503.38 |
|
|
|
8,234 |
|
|
$ |
489.84 |
|
Distributed |
|
|
(73,623 |
) |
|
$ |
383.21 |
|
|
|
(66,977 |
) |
|
$ |
417.26 |
|
|
|
(4,378 |
) |
|
$ |
367.88 |
|
Forfeited |
|
|
(6,752 |
) |
|
$ |
470.05 |
|
|
|
(7,545 |
) |
|
$ |
499.19 |
|
|
|
(377 |
) |
|
$ |
517.31 |
|
Adjustment for performance |
|
|
— |
|
|
$ |
— |
|
|
|
38,268 |
|
|
$ |
417.25 |
|
|
|
— |
|
|
$ |
— |
|
December 31, 2025 |
|
|
166,860 |
|
|
$ |
407.46 |
|
|
|
84,504 |
|
|
$ |
496.69 |
|
|
|
19,022 |
|
|
$ |
523.83 |
|
The weighted-average grant-date fair value per share of service-based restricted stock awards granted during 2025, 2024 and 2023 was $510.86, $553.17 and $369.18, respectively. The weighted-average grant-date fair value per share of performance-based restricted stock awards granted during 2025, 2024 and 2023 was $503.38, $595.00 and $392.73, respectively. The weighted-average grant-date fair value per share of incentive compensation stock awards granted during 2025, 2024 and 2023 was $489.84, $548.68 and $362.08, respectively.
The aggregate intrinsic values for unvested service-based and performance-based restricted stock awards of $157 million and unvested incentive compensation stock awards of $4 million at December 31, 2025 were based on the closing price of the Company’s common stock at December 31, 2025, which was $622.66. The aggregate intrinsic values of service-based and performance-based restricted stock awards distributed during the years ended December 31, 2025, 2024 and 2023 were $74 million, $76 million and $48 million, respectively. The aggregate intrinsic values of incentive compensation stock awards distributed during the years ended December 31, 2025, 2024 and 2023 were $1 million, $4 million and $4 million, respectively. The aggregate intrinsic values for distributed awards were based on the closing prices of the Company’s common stock on the dates of distribution.
Prior to 2016, under the Plans, the Company granted options to employees to purchase its common stock at a price equal to the closing market value at the date of grant. Options became exercisable in four annual installments beginning one year after date of grant. Outstanding options expired ten years after the grant date.
The following table includes summary information for stock options as of December 31, 2025:
|
|
Number of |
|
|
Weighted- |
|
||
Outstanding at January 1, 2025 |
|
|
3,623 |
|
|
$ |
154.58 |
|
Exercised |
|
|
(3,623 |
) |
|
$ |
154.58 |
|
Outstanding at December 31, 2025 |
|
|
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
||
Exercisable at December 31, 2025 |
|
|
- |
|
|
$ |
- |
|
The aggregate intrinsic values of options exercised during each of the three years ended December 31, 2025, 2024 and 2023 were immaterial.
At December 31, 2025, there were approximately 0.3 million awards available for grant under the Plans.
In 1996, the Company adopted the Shareholder Value Achievement Plan to award shares of the Company’s common stock to key senior employees based on certain common stock performance criteria over a long-term period. As of December 31, 2025, 0.2 million shares of common stock remain reserved for issuance. No awards have been granted under this plan since 2000.
The Company adopted and the shareholders approved the Common Stock Purchase Plan for Directors in 1996, which provides nonemployee members of the Board of Directors the election to receive all or a portion of their total fees in the form of the Company’s common stock. Beginning in 2016, members of the Board of Directors were not required to defer any of their fees in the form of the Company’s common stock. Under the terms of this plan, 0.3 million shares of common stock were reserved for issuance. Nonemployee members of the Board of Directors elected to defer portions of their fees representing 826, 834 and 1,333 shares of the Company’s common stock under this plan during 2025, 2024 and 2023, respectively.
The following table summarizes stock-based compensation expense for the years ended December 31, 2025, 2024 and 2023, unrecognized compensation cost for nonvested awards at December 31, 2025 and the weighted-average period over which unrecognized compensation cost will be recognized:
(in millions, except year data) |
|
Restricted |
|
|
Incentive |
|
|
Directors’ |
|
|
Total |
|
||||
Stock-based compensation expense recognized for |
|
|
|
|
|
|
|
|
|
|
|
|
||||
2025 |
|
$ |
45 |
|
|
$ |
1 |
|
|
$ |
— |
|
|
$ |
46 |
|
2024 |
|
$ |
56 |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
58 |
|
2023 |
|
$ |
49 |
|
|
$ |
1 |
|
|
$ |
— |
|
|
$ |
50 |
|
Unrecognized compensation cost at |
|
$ |
28 |
|
|
$ |
1 |
|
|
$ |
— |
|
|
$ |
29 |
|
Weighted-average period over which unrecognized |
|
2.1 years |
|
|
1.6 years |
|
|
|
|
|
|
|
||||
Total tax benefits related to stock-based compensation expense were $8 million, $9 million and $9 million for the years ended December 31, 2025, 2024 and 2023, respectively.
The following presents expected stock-based compensation expense in future periods for outstanding awards as of December 31, 2025:
(in millions) |
|
|
|
|
2026 |
|
$ |
18 |
|
2027 |
|
|
9 |
|
2028 |
|
|
1 |
|
2029 |
|
|
1 |
|
Total |
|
$ |
29 |
|
Stock-based compensation expense is primarily included in Selling, general and administrative expenses in the Company’s consolidated statements of earnings.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2024 | Feb 21, 2025 | |
| 2023 | Feb 23, 2024 | |
| 2022 | Feb 24, 2023 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.